Article content
The B.C. Ministry of Health has come under fire for rejecting a COVID-19 drug treatment engineered in Vancouver that has been approved for use by Health Canada.
In a prepared statement, U.S. pharmaceutical company Eli Lilly claimed the ministry of health “came to this decision after a limited appraisal of a manuscript from a single phase 2 trial as accepted for publication by the (New England Journal of Medicine.)
We apologize, but this video has failed to load.
Try refreshing your browser, or U.S. pharmaceutical giant lashes out at B.C. Ministry of Health after drug rejection Back to video
Article content
A Health Canada-approved antibody drug engineered by a Vancouver biotech company to treat COVID-19 is not being used in B.C.
The drug bamlanivimab is made by U.S. pharmaceutical giant Eli Lilly using technology from AbCellera Biologics. AbCellera is valued at over US$10 billion since its debut on the NASDAQ exchange last month.
We apologize, but this video has failed to load.
Try refreshing your browser, or Health Canada-approved COVID-19 treatment drug rejected by British Columbia Back to video
The drug was given emergency approval as a COVID-19 treatment in the U.S. and Canada in November. It is administered using a one-hour intravenous infusion and is targeted at people at risk of developing severe symptoms and getting respirated.